Fresh Tracks Therapeutics Inc (FRTX) Annual Balance Sheets

Annual · GAAP · USD millions
Access FRTX quarterly Balance Sheets →
Balance sheet data covering Fresh Tracks Therapeutics Inc–Dec 31 2019 offers a view into how Dec 31 2023's financial position has changed alongside business activity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2023)
(Dec 31 2022) (Dec 31 2021) (Dec 31 2020) (Dec 31 2019)
Assets
Cash & cash equivalent10.87
Marketable Securities0.00
Cash & Short-term Investments10.00
Prepaid Expense And Other Assets Current0.68
Total Current Assets11.55
Equipment/Property/Plant Net0.03
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset-
Total Assets11.59
Liabilities
Accounts Payable, Current AC0.41
Accrued Liabilities, Current AC1.25
Short-term Debt0.00
Other Liabilities, Current0.00
Total Current Liabilities1.66
Long-term debt0.00
Total Long-term Debt0.00
Operating Lease Liability Current-
Operating Lease Liability Noncurrent0.00
Total Liabilities1.66
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock182.03
Retained Earnings / Accumulated Deficit-172.16
Other Equity0.00
Common Stockholder's Equity9.93
Total Stockholder's Equity9.93
Liabilities & Stockholder's Equity11.59
4 historic quarters locked

Sign in to unlock the full Fresh Tracks Therapeutics Inc balance sheet history.

About Fresh Tracks Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-24-011460

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License